FAQ
Answers to frequently asked questions about our pharmaceutical packaging solutions, services, sustainability, and Innovation Hub.
Palladio Group
Yes. Sustainability is a key pillar of the company’s strategy. Palladio Group develops sustainable pharmaceutical packaging solutions by promoting the use of certified materials and actively investing in eco-design. Furthermore, the company uses Life Cycle Assessment (LCA) to measure and reduce the environmental impact of its production processes.
Source: https://palladiogroup.com/services/#item-sustainability
Yes. All pharmaceutical packaging is tailor-made by taking into account the specific characteristics of the medicine, regulatory requirements, logistical needs, manufacturing processes, and the customer’s sustainability goals.
Source: https://palladiogroup.com/
Yes. The company develops dedicated solutions for clinical trials, including decentralised and hybrid studies.
You can contact Palladio Group using the form on the Contact page of the website to receive a personalised consultation.
Palladio Group designs and manufactures secondary packaging solutions for the pharmaceutical industry. The company develops folding cartons, leaflets, labels, assemblies, blister foils, special products for clinical trials, Smart Packaging, and services dedicated to the supply chain, serialisation, and medicine safety, offering tailored solutions for pharmaceutical companies.
Source: https://palladiogroup.com/
The portfolio includes a wide range of solutions dedicated to healthcare, including folding cartons, leaflets, labels, assemblies, blister foils, special products for clinical trials, Smart Packaging, and customised solutions.
The company offers various services, including artwork development for pharmaceutical packaging, serialisation, tamper-evident system integration, Vendor-Managed Inventory (VMI), Just-In-Time (JIT) logistics, application of authentication seal, technical consultancy, supply chain management, packaging Life Cycle Assessment (LCA), and new product launch support.
The Group has seven production facilities in Italy and abroad, specialising in pharmaceutical packaging and related services.
Source: https://palladiogroup.com/group/
Product catalogues and special label catalogues are available to view in the Download Area of the website.
Products
Yes. We use light yet resilient paper weights that allow us to print multilingual leaflets or those with extensive text, ensuring they fit into small folding cartons while maintaining excellent legibility for the patient.
Assemblies are advanced packaging solutions that combine different paperboard components into a single functional, practical, and secure unit.
Source: https://palladiogroup.com/product/composite-packaging-solutions/
The use of RFID and NFC labels guarantees product authenticity, effectively combats counterfeiting, and streamlines logistical tracking, while improving therapeutic adherence through more direct interaction between the company, healthcare professionals, and patients.
Source: https://palladiogroup.com/product/labels/smart-labels/
Assemblies include Flowpack, which encapsulates components in a flexible, protective barrier, heat-sealable paper bands, and folding cartons with integrated leaflets.
Source: https://palladiogroup.com/product/composite-packaging-solutions/
Smart Packaging is packaging that integrates digital technologies directly onto the carton or label to improve traceability, guarantee drug safety, support therapeutic adherence, and facilitate interaction with patients and healthcare professionals.
Solutions for clinical trials include Booklet, Tear-Off, and Peel-Off labels, leaflets, and tamper-evident cartons such as TECOBOX. The range also encompasses advanced solutions like PluggyMed and RFID/NFC technologies, ideal for decentralised trials.
Palladio Group uses high-resolution flexographic printing within a Clean Room environment. This technology enables complex graphics to be applied directly onto aluminium substrates.
Palladio Group’s folding cartons can include embossed Braille printing, various special coatings or finishes, and tamper-evident security systems integrated directly onto the packaging.
The company manufactures pharmaceutical leaflets in a variety of configurations. Production includes booklet leaflets, leaflets with glue dot closure, leaflets with closure label, and Patient Alert Cards.
The company designs and manufactures pharmaceutical folding cartons that can be customised by format, design, and materials. The range includes packaging for blisters, bottles, tamper-evident solutions (TECOBOX), options with integrated leaflets, hanging tabs, trays, vial holders, and counter displays.
The company produces a range of self-adhesive pharmaceutical labels designed to ensure maximum adhesion and legibility. The offering includes multi-page, hanging, removable, security, transparent, and finished labels, as well as Smart Labels for advanced traceability.
Palladio Group offers standard plain or printed primary packaging solutions, as well as high-resistance special solutions ideal for Child-Resistant and Senior-Friendly packaging.
Services
The artwork development service supports pharmaceutical companies in correctly integrating the requirements of the Falsified Medicines Directive (FMD). The company optimises the graphic layout of cartons to ensure adequate space for printing the DataMatrix code and serialisation, whilst guaranteeing structural adaptations for applying tamper-evident systems and maintaining full compliance with international regulatory standards.
Source: https://palladiogroup.com/services/#item-product-development
Palladio Group manages the entire pharmaceutical serialisation process to ensure maximum drug traceability. The company assists clients from feasibility studies through to implementation, directly overseeing both the marking design on the artwork and the integration of the platform with corporate IT systems.
Source: https://palladiogroup.com/services/#item-traceability-and-security
Palladio Group has established a dedicated multidisciplinary team comprising legal, environmental, and structural design experts to ensure complete regulatory compliance and turn these new European challenges into genuine opportunities for sustainable innovation.
Source: https://palladiogroup.com/services/#item-sustainability
The company provides comprehensive support for clinical trials, assisting clients from the initial development and co-design of the packaging. It also manages randomisation and the printing of variable data, optimising supply chain and logistics planning.
The support offered to clients includes product development, technical support, supply chain and logistics management, as well as traceability, safety, and sustainability solutions, along with a full end-to-end service.
Serialisation can be direct, printed directly onto the surface of the carton, or indirect, applied via a self-adhesive label. Both solutions ensure full compliance with Directive 2011/62/EU and the regulatory requirements of Italy, Europe, Russia, China, Saudi Arabia, and South Korea.
Source: https://palladiogroup.com/services/#item-traceability-and-security
Sustainability
The company foresees that by 2029, 82% of its suppliers will, in turn, have to adopt specific science-based emissions reduction targets that have been formally approved.
The company’s commitment to responsible and sustainable business practices has been recognised with the EcoVadis Gold Medal. This milestone certifies the company’s environmental, ethical, and social performance, placing it in the top 5% of companies assessed worldwide by EcoVadis.
Yes, Palladio Group’s near-term science-based emissions reduction target has been officially approved by the Science Based Targets initiative (SBTi). This means the company’s decarbonisation strategy is anchored in the most rigorous global scientific criteria and is aligned with the international scenario aimed at limiting global warming to 1.5°C.
Palladio Group has defined a transparent and measurable roadmap to reduce its environmental impact. The company is committed to reducing absolute Scope 1 and Scope 2 emissions by 63% by 2034. Regarding logistics and the value chain, the target includes a 66% reduction in Scope 3 emissions (per value added in EUR) by 2034. Furthermore, the use of clean energy will be gradually increased to reach 100% renewable electricity by 2030.
The Sustainability Report and the Extract are available to view in the Download Area of the website.
Palladio Group operates according to the highest standards of the pharmaceutical sector, holding the main certifications for quality and sustainability. All official documentation is always available to view in the Download Area of the website.
Innovation Hub
The Innovation Hub focuses its research and development on 5 strategic pillars: Alternatives to Plastic, Smart Packaging, Expert Services, Special Labels, and Clinical Trials.
It is Palladio Group’s research and collaboration centre dedicated to developing the pharmaceutical packaging of the future. The Hub works in synergy with start-ups, universities, and industry organisations to design and test sustainable and innovative healthcare solutions.
The Innovation Hub’s flagship solutions and case studies include: TECOBOX, Multipack Handle®, Smart Pill Pocket, TREATMENT, pressed paper trays, co-design kits, and PluggyMed.





